In conclusion, the present analysis implicated that elevated SNHG7 is strongly associated with OS, tumor progression, LNM and DM in carcinomas, and may be served as a promising biomarker to guide therapy for various cancer patients. This evidence concerns the gene SNHG7 and carcinoma.